cialis prices
Point-of-care testing (POCT) and Near-patient testing (NPT) are used synonymously to describe analytical procedures performed for patients by healthcare professionals outside of the conventional laboratory. Advances in technology have led to the development of instruments and kits designed for use in this role and which are able to provide an increasing repertoire of tests
STAB VIDA's consortium, HILYSENS will be the first lab-on-a-chip tool allowing specific and sensitive detection of acute, chronic and autoimmunity associated Lyme Disease and ensuring non-invasive, fast, specific and easy diagnosing, prognosis and monitoring. Optimisation of resources, reduction of the associated costs and an increase in the quality of care are some of the potential impacts of HILYSENS.
HILYSENS is a 2 year R+D project funded by the European Commission's (FP7) under Research for the Benefit of the SMEs. the project officially started on November 1st 2010. The Kick-off Meeting was held in Barcelona on November 8th and was hosted by AROMICS at the PCB.



